Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
RemedyBio Completes €10.5M Financing from European Innovation Council
RemedyBio, an immunology focused discovery and development company, today announces the final closing of an […]
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round
Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of […]
PEP-Therapy Extends Series-A Financing, Raising a Total of €5.4 Million to Progress the Clinical Development of its Lead Candidate PEP-010
PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of […]
Entos Raises $53 Million Series A Round Led by Coatue and Catalio
Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology […]
Mammoth Scientific Launches $100 Million Venture Capital Fund
Mammoth™ Scientific, a health science and technology venture capital firm, announced the launch of a […]
NHS Investment Boost to Ambulance Staff Numbers Ahead of Winter
Ambulance Trusts in England will be given an extra £55 million to boost staff numbers […]
Intuitap Medical's Disruptive Spinal Tap Technology Enters Clinical Trials as they Close Successful $5.5m Series a Round of Funding Led by the Pink Ceiling and Curate Capital
IntuiTap Medical, a cutting-edge medical device company with technology poised to change the spinal tap, […]
‘Skin Snaps’ and Rapid Tests Among £20 Million NHS Push to Speed Cancer Diagnosis
‘Skin snaps’ and rapid tests for same day diagnosis are among a package of measures […]
Stem Cell Therapy Company Amniotics Raises SEK 60 Million
Amniotics AB (publ) (“Amniotics” or the “Company”), a stem cell therapy company has raised SEK60 million through […]
IW Capital Announces Investment in E-Pharmacy Platform SimplyMeds
IW Capital is proud to announce their investment in e-pharmacy company SimplyMeds, marking the first external investment in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more